Newron Pharmaceuticals S.p.A. (ETR:NP5)
21.50
+0.50 (2.38%)
At close: Feb 13, 2026
Revenue by Product
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.